Your Input: | |||||
GCG | Glicentin-related polypeptide; Glucagon plays a key role in glucose metabolism and homeostasis. Regulates blood glucose by increasing gluconeogenesis and decreasing glycolysis. A counterregulatory hormone of insulin, raises plasma glucose levels in response to insulin-induced hypoglycemia. Plays an important role in initiating and maintaining hyperglycemic conditions in diabetes. GLP-2 stimulates intestinal growth and up-regulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. The gastrointestinal tract, fro [...] (180 aa) | ||||
MTRNR2L1 | Humanin-like 1; Plays a role as a neuroprotective and antiapoptotic factor. Belongs to the humanin family. (24 aa) | ||||
MTRNR2L8 | Humanin-like 8; Plays a role as a neuroprotective and antiapoptotic factor. Belongs to the humanin family. (24 aa) | ||||
MTRNR2L12 | MT-RNR2 like 12. (24 aa) | ||||
MTRNR2L3 | Humanin-like 3; Plays a role as a neuroprotective and antiapoptotic factor. Belongs to the humanin family. (24 aa) | ||||
MTRNR2L10 | Humanin-like 10; Plays a role as a neuroprotective and antiapoptotic factor. Belongs to the humanin family. (24 aa) | ||||
MTRNR2L7 | Humanin-like 7; Plays a role as a neuroprotective and antiapoptotic factor. Belongs to the humanin family. (24 aa) | ||||
FZD3 | Frizzled-3; Receptor for Wnt proteins. Most of frizzled receptors are coupled to the beta-catenin canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes. A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to i [...] (666 aa) | ||||
PAK2 | Serine/threonine-protein kinase PAK 2; Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell motility, cell cycle progression, apoptosis or proliferation. Acts as downstream effector of the small GTPases CDC42 and RAC1. Activation by the binding of active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Full-length PAK2 stimulates cell survival and cell growth. Phosphorylates MAPK4 and MAPK6 and activates the downstream targ [...] (524 aa) | ||||
CIDEA | Cell death activator CIDE-A; Acts as a CEBPB coactivator in mammary epithelial cells to control the expression of a subset of CEBPB downstream target genes, including ID2, IGF1, PRLR, SOCS1, SOCS3, XDH, but not casein. By interacting with CEBPB, strengthens the association of CEBPB with the XDH promoter, increases histone acetylation and dissociates HDAC1 from the promoter (By similarity). Binds to lipid droplets and regulates their enlargement, thereby restricting lipolysis and favoring storage. At focal contact sites between lipid droplets, promotes directional net neutral lipid tran [...] (219 aa) | ||||
RFFL | E3 ubiquitin-protein ligase rififylin; E3 ubiquitin-protein ligase that regulates several biological processes through the ubiquitin-mediated proteasomal degradation of various target proteins. Mediates 'Lys-48'-linked polyubiquitination of PRR5L and its subsequent proteasomal degradation thereby indirectly regulating cell migration through the mTORC2 complex. Ubiquitinates the caspases CASP8 and CASP10, promoting their proteasomal degradation, to negatively regulate cell death downstream of death domain receptors in the extrinsic pathway of apoptosis. Negatively regulates the tumor ne [...] (363 aa) | ||||
CXCR3 | C-X-C chemokine receptor type 3; [Isoform 1]: Receptor for the C-X-C chemokine CXCL9, CXCL10 and CXCL11 and mediates the proliferation, survival and angiogenic activity of human mesangial cells (HMC) through a heterotrimeric G- protein signaling pathway. Binds to CCL21. Probably promotes cell chemotaxis response. [Isoform 3]: Mediates the activity of CXCL11. (415 aa) | ||||
BCL2L1 | Bcl-2-like protein 1; Potent inhibitor of cell death. Inhibits activation of caspases. Appears to regulate cell death by blocking the voltage- dependent anion channel (VDAC) by binding to it and preventing the release of the caspase activator, CYC1, from the mitochondrial membrane. Also acts as a regulator of G2 checkpoint and progression to cytokinesis during mitosis. Isoform Bcl-X(S) promotes apoptosis. (233 aa) | ||||
DFFA | DNA fragmentation factor subunit alpha; Inhibitor of the caspase-activated DNase (DFF40). (331 aa) | ||||
RNF34 | E3 ubiquitin-protein ligase RNF34; E3 ubiquitin-protein ligase that regulates several biological processes through the ubiquitin-mediated proteasomal degradation of various target proteins. Ubiquitinates the caspases CASP8 and CASP10, promoting their proteasomal degradation, to negatively regulate cell death downstream of death domain receptors in the extrinsic pathway of apoptosis. May mediate 'Lys-48'-linked polyubiquitination of RIPK1 and its subsequent proteasomal degradation thereby indirectly regulating the tumor necrosis factor-mediated signaling pathway. Negatively regulates p5 [...] (373 aa) | ||||
MTRNR2L11 | Humanin-like 11; Plays a role as a neuroprotective and antiapoptotic factor. Belongs to the humanin family. (24 aa) | ||||
MTRNR2L13 | Humanin-like 13; Plays a role as a neuroprotective and antiapoptotic factor. Belongs to the humanin family. (24 aa) | ||||
MTRNR2L6 | Humanin-like 6; Plays a role as a neuroprotective and antiapoptotic factor. Belongs to the humanin family. (24 aa) | ||||
MTRNR2L4 | Humanin-like 4; Plays a role as a neuroprotective and antiapoptotic factor. Belongs to the humanin family. (28 aa) | ||||
MTRNR2L5 | Humanin-like 5; Plays a role as a neuroprotective and antiapoptotic factor. Belongs to the humanin family. (24 aa) |